2023 annual financial data
Cellectar Biosciences 2023 Net income growth
Direct answer
Net income growth was -49.54%.
Operating income was -38,960,643 USD and net income was -42,770,610 USD.
Operating cash flow was -32,376,974 USD.
Get free Cellectar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -38,960,643 USD
- Net income
- -42,770,610 USD
- Operating cash flow
- -32,376,974 USD